Atropa bella-donna

Glavne informacije

  • Zaščiteno ime:
  • Atropa bella-donna C12 kroglice
  • Koda artikla:
  • /
  • Farmacevtska oblika:
  • kroglica
  • Sestava:
  • Atropa bella-donna 1 NEDEFINIRANO / 1 g
  • Pot uporabe:
  • Peroralna/sublingvalna uporaba
  • Enote v paketu:
  • stekleni vsebnik z 10 g kroglic
  • Tip zastaranja:
  • BRp - Izdaja zdravila je brez recepta v lekarnah.
  • Uporabi za:
  • ljudje
  • Vrsta medicine:
  • Alopatska drog

Dokumentov

Lokalizacija

  • Na voljo v:
  • Atropa bella-donna C12 kroglice
    Slovenija
  • Jezik:
  • slovenščina

Terapevtski podatki

  • Terapevtska skupina:
  • -

Drugi podatki

Stanje

  • Source:
  • JAZMP - Javna agencija RS za zdravila in medicinske pripomočke - Slovenia Medicines Agency
  • Status dovoljenje:
  • Zdravilo z dovoljenjem za promet
  • Številka dovoljenja:
  • HH/11/00005/6
  • Datum dovoljenje:
  • 30-03-2011
  • EAN koda:
  • 3837000063493
  • Zadnja posodobitev:
  • 19-01-2018

21-11-2018

Implementation and verification of PBPK modelling codes of TCDD in rats and humans into Berkeley Madonna

Implementation and verification of PBPK modelling codes of TCDD in rats and humans into Berkeley Madonna

Published on: Tue, 20 Nov 2018 The goal of the current work was to implement and verify previously published rat and human PBPK modelling codes for TCDD into Berkeley Madonna. The US‐EPA has used these PBPK models in the reassessment of TCDD. A procurement contract has been set up to explore the possibilities to adequately run the models and reproduce previously published results. The implementation of the available codes in Berkeley Madonna was carried out at RIKILT‐WUR under the framework agreement wi...

Europe - EFSA - European Food Safety Authority Publications

20-12-2018


Orphan designation: Acetylleucine, Treatment of spinocerebellar ataxia, 22/11/2018, Positive

Orphan designation: Acetylleucine, Treatment of spinocerebellar ataxia, 22/11/2018, Positive

Orphan designation: Acetylleucine, Treatment of spinocerebellar ataxia, 22/11/2018, Positive

Europe - EMA - European Medicines Agency